Oaktree Specialty Lending Corp

Oaktree Specialty Lending Corp

OCSL · NASDAQ · Financial Services / Asset Management

12.16USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close12.16
Open12.22
Day Range12.05 – 12.22
52-Week Range10.06 – 12.98
Volume244.10K
Market Cap1.07B
P/E (TTM)25.21
Forward P/E8.94
EPS0.48
Dividend Yield10.91%
Beta0.57
50-Day Avg12.54
200-Day Avg12.23

About

Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.

Company Details

  • SectorFinancial Services
  • IndustryAsset Management
  • CEOMr. Armen Panossian J.D.
  • Employees0
  • Headquarters333 South Grand Avenue, Los Angeles, CA, United States, 90071, USA
  • Websitehttps://www.oaktreespecialtylending.com

Leadership

  • Mr. Armen Panossian J.D.CEO & Co-Chief Investment Officer · b. 1976
  • Mr. Mathew M. PendoPresident · b. 1964
  • Dr. Aman Kumar M.D.Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending · b. 1981
  • Mr. Christopher McKownCFO & Treasurer · b. 1982
  • Mr. Brett McKeoneChief Operating Officer
  • Mr. Raghav KhannaCo-Chief Investment Officer · b. 1984
  • Mr. Dane KlevenSenior VP & Head of Investor Relations
  • Ms. Mary Gallegly J.D.MD,General Counsel & Secretary
  • Ms. Ashley PakChief Compliance Officer · b. 1978
  • Mr. Sandeep Kumar KhoranaManaging Director of Origination · b. 1973

Financials

Income Statement

Currency: USD2008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue33.28M24.02M49.83M110.03M141.87M111.10M125.24M29.09M247.87M177.96M57.31M127.13M52.31M248.31M39.11M125.20M186.23M299.70M
Growth (%)--27.82%+107.42%+120.81%+28.94%-21.69%+12.72%-76.78%+752.20%-28.20%-67.79%+121.81%-58.85%+374.63%-84.25%+220.11%+48.74%+60.93%
Cost of Revenue917.04K17.83M25.59M44.38M55.44M73.19M99.92M84.27M291.48M361.64M120.00K50.32M39.26M71.40M55.66M-223.56M128.62M38.33M
Gross Profit32.36M24.02M49.83M110.03M141.87M111.10M125.24M29.09M-43.61M-183.67M57.20M127.13M52.31M248.31M39.11M125.20M57.61M261.37M
Gross Margin97.24%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-17.59%-103.21%99.79%100.00%100.00%100.00%100.00%100.00%30.94%87.21%
Operating Expense29.11M17.19M25.48M64.68M39.23M-24.19M-38.76M-42.96M-31.67M-36.64M-25.92M-43.00K14.86M7.46M-40.68M-55.57M-185.00K110.35M
Operating Income3.26M6.83M24.35M45.34M102.65M135.29M164.00M72.05M-11.94M-147.03M83.11M127.17M37.45M240.84M79.79M180.78M57.80M151.02M
Operating Margin9.79%28.43%48.86%41.21%72.35%121.77%130.95%247.71%-4.81%-82.62%145.01%100.03%71.59%96.99%204.00%144.38%31.03%50.39%
EBITDA20.21M6.83M24.35M45.34M102.65M135.29M164.00M72.05M-11.94M-147.03M83.11M127.17M37.45M126.32M216.04M180.78M57.80M151.02M
EBITDA Margin60.71%28.43%48.86%41.21%72.35%121.77%130.95%247.71%-4.81%-82.62%145.01%100.03%71.59%50.87%552.34%144.38%31.03%50.39%
Net Income3.26M6.19M22.42M30.21M79.40M101.82M112.53M15.39M-66.56M-196.97M46.76M126.16M39.22M237.26M29.22M117.33M57.91M33.92M
Net Income Margin9.79%25.78%44.99%27.45%55.97%91.64%89.85%52.93%-26.85%-110.68%81.59%99.24%74.98%95.55%74.71%93.71%31.09%11.32%
R&D--------0.5431.862.010.750.291.020.120.34--
R&D as % of Total Revenue--------0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%--
Interest Expense917.04K636.90K1.93M15.14M23.25M33.47M51.47M56.65M54.62M49.94M35.73M32.43M26.29M30.52M46.93M111.64M128.62M115.84M
Interest Expense % of Total Revenue2.76%2.65%3.87%13.76%16.38%30.12%41.09%194.78%22.04%28.06%62.34%25.51%50.25%12.29%119.98%89.17%69.06%38.65%

Balance Sheet

Currency: USD2007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets107.33M299.15M415.89M651.93M1.21B1.39B2.07B2.67B2.59B2.35B1.62B1.55B1.48B1.64B2.64B2.65B3.22B3.20B3.00B
Total Liabilities514.00K4.81M5.33M82.75M481.09M485.43M703.46M1.19B1.23B1.21B748.39M693.42M550.41M725.83M1.32B1.40B1.70B1.71B1.54B
Total Equity106.82M294.34M410.56M569.17M728.63M903.57M1.37B1.48B1.35B1.14B867.66M858.03M930.63M914.88M1.31B1.25B1.52B1.49B1.47B
Cash17.65M22.91M113.21M76.77M67.64M74.39M143.29M86.73M138.38M117.92M53.02M13.38M15.41M39.10M29.33M23.53M136.45M63.97M79.63M
Total Debt---73.00B598.02M466.25M646.00M1.15B1.20B1.78B1.09B637.21M631.91M709.32M1.27B1.30B1.60B1.64B1.49B
Net Debt--22.91M-113.21M-76.77M530.38M391.86M502.71M1.07B1.06B1.04B622.35M623.83M457.96M670.22M1.24B1.28B1.46B1.57B1.41B

Cash Flow

Currency: USD2008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow-179.38M-19.68M-239.16M-517.92M-91.56M-461.66M-546.34M146.19M164.76M486.90M53.51M215.82M-152.88M-230.52M22.39M228.76M19.08M142.40M
Investing Cash Flow-202.40B-61.81B-325.22B-703.41M-519.50M-1.22B-1.26B-675.92M-578.87M-644.23M-755.74M------85.98M
Financing Cash Flow184.63M109.97M202.72M508.80M96.97M532.19M489.78M-94.55M-185.21M-557.35M-99.93M-214.11M176.33M224.19M-26.82M-110.41M-86.77M-229.35M
Capital Expenditure300000000000000000
Free Cash Flow-179.38M-19.68M-239.16M-517.92M-91.56M-461.66M-546.34M146.19M164.76M486.90M53.51M215.82M-152.88M-230.52M22.39M228.76M19.08M142.40M
Dividends Paid8.87M27.14M41.82M76.70M91.87M115.44M132.47M114.69M100.26M62.52M54.97M52.22M53.10M79.85M115.25M180.05M176.81M148.20M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF-4.95%-137.91%-17.49%-14.81%-100.33%-25.01%-24.25%78.45%60.85%12.84%102.74%24.20%-34.73%-34.64%514.61%78.70%926.89%104.07%

Earnings

Report DateAug 7, 2008Dec 10, 2008Feb 5, 2009May 6, 2009Aug 5, 2009Dec 9, 2009Feb 9, 2010May 5, 2010Aug 4, 2010Dec 2, 2010Jan 31, 2011May 4, 2011Aug 3, 2011Nov 29, 2011Feb 8, 2012May 8, 2012Aug 8, 2012Nov 28, 2012Feb 6, 2013May 8, 2013Aug 7, 2013Nov 25, 2013Feb 6, 2014May 8, 2014Aug 7, 2014Dec 1, 2014Feb 9, 2015May 11, 2015Aug 10, 2015Dec 1, 2015Feb 9, 2016May 10, 2016Aug 9, 2016Nov 29, 2016Feb 9, 2017May 10, 2017Aug 9, 2017Nov 29, 2017Feb 8, 2018May 8, 2018Aug 8, 2018Nov 29, 2018Feb 7, 2019May 8, 2019Aug 7, 2019Nov 20, 2019Feb 6, 2020May 7, 2020Aug 10, 2020Nov 19, 2020Feb 4, 2021May 6, 2021Aug 5, 2021Nov 16, 2021Feb 3, 2022May 5, 2022Aug 4, 2022Nov 15, 2022Feb 7, 2023May 4, 2023Aug 3, 2023Nov 14, 2023Feb 1, 2024Apr 30, 2024Aug 1, 2024Nov 19, 2024Feb 4, 2025May 1, 2025Aug 5, 2025Nov 18, 2025Feb 4, 2026May 5, 2026Aug 5, 2026Nov 17, 2026
EPS Estimate0.960.861.000.971.040.780.680.800.780.650.770.830.780.790.840.780.790.810.830.850.830.780.750.790.790.780.780.630.580.590.550.530.540.550.540.450.400.400.310.280.310.320.320.350.360.350.350.310.330.360.390.410.410.450.500.510.540.550.610.630.630.630.610.580.560.560.540.490.450.390.380.370.360.34
EPS Actual1.050.961.080.991.050.780.660.780.780.630.780.810.720.750.810.780.720.780.570.810.750.690.780.750.750.750.690.570.630.540.540.540.600.540.480.390.420.240.270.330.300.360.360.390.360.360.300.480.360.510.210.420.570.480.510.540.510.540.610.620.620.620.570.560.540.550.540.450.370.400.410.380.37-
Surprise9.38%11.63%8.00%2.06%0.96%0.00%-2.94%-2.50%0.00%-3.08%1.30%-2.41%-7.69%-5.06%-3.57%0.00%-8.86%-3.70%-31.33%-4.71%-9.64%-11.54%4.00%-5.06%-5.06%-3.85%-11.54%-9.52%8.62%-8.47%-1.82%1.89%11.11%-1.82%-11.11%-13.33%5.00%-40.00%-12.90%17.86%-3.23%12.50%12.50%11.43%0.00%2.86%-14.29%54.84%9.09%41.67%-46.15%2.44%39.02%6.67%2.00%5.88%-5.56%-1.82%0.00%-1.59%-1.59%-1.59%-6.56%-3.45%-3.57%-1.79%0.00%-8.16%-17.78%2.56%7.89%2.70%2.78%-
TimingPre-market-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.07B
Enterprise Value2.47B
Trailing P/E25.21
Forward P/E8.94
PEG Ratio0.93
Price / Sales3.65
Price / Book0.77
EPS0.48
Book Value15.70
Revenue (TTM)292.23M
Gross Profit (TTM)292.23M
Profit Margin14.45%
Operating Margin81.60%
Return on Equity2.95%
Return on Assets5.19%
Shares Outstanding88.09M
Shares Float0
Beta0.57
Dividend Yield10.91%
Dividend Rate1.32
Payout Ratio94.23%

Analyst Ratings

Hold
Based on 6 analystsTarget 12.50
  • Strong Buy
    1
  • Hold
    5

Ownership Breakdown

Institutions
50.62%
Insiders
0.30%
Retail / Other
49.08%

Top Institutional Holders

  • Private Management Group Inc
    3.72M4.22%
  • Morgan Stanley - Brokerage Accounts
    2.56M2.91%
  • Bruni J V & Co
    2.47M2.81%
  • Ares Management LLC
    2.20M2.50%
  • Generali Asset Management SPA SGR
    2.08M2.36%
  • Oaktree Capital Management LLC
    1.85M2.10%
  • Van Eck Associates Corporation
    1.70M1.93%
  • Claret Asset Management Corporation
    1.67M1.90%
  • UBS Group AG
    1.37M1.55%
  • Melia Wealth LLC
    1.24M1.41%
  • Legal & General Group PLC
    685.01K0.78%
  • Royal Bank of Canada
    479.66K0.54%
  • Beach Point Capital Management LP
    453.52K0.51%
  • BlackRock Inc
    341.86K0.39%
  • Two Sigma Investments LLC
    340.28K0.39%
  • Muzinich & Co Inc
    334.74K0.38%

Top Fund Holders

  • VanEck BDC Income ETF
    1.73M1.97%
  • Putnam BDC Income ETF
    665.14K0.76%
  • Accelerate Divers Crdt Inc ETF
    343.03K0.39%
  • iShares Listed Private Eq ETF USD Dist
    336.77K0.38%

Dividends

20263×
0.33Sep 15, 20260.34Jun 15, 20260.40Mar 16, 2026
20254×
0.40Dec 15, 20250.40Sep 15, 20250.42Jun 16, 20250.47Mar 17, 2025
20244×
0.55Dec 16, 20240.55Sep 16, 20240.55Jun 14, 20240.55Mar 14, 2024
20234×
0.62Dec 14, 20230.55Sep 14, 20230.55Jun 14, 20230.55Mar 14, 2023
20224×
0.96Dec 14, 20220.51Sep 14, 20220.49Jun 14, 20220.48Mar 14, 2022
20214×
0.47Dec 14, 20210.43Sep 14, 20210.39Jun 14, 20210.36Mar 12, 2021
20201×
0.33Dec 14, 2020

Stock Splits

  • Jan 23, 20231:3